Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ctDNA Monitoring Cancer Recurrence and Its Clinical Value in Solid Tumor

NCT06028516 is registered in ClinicalTrials.gov with Shandong First Medical University as lead sponsor.

NCT NCT06028516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06028516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ctDNA Monitoring Cancer Recurrence and Its Clinical Value in Solid Tumor
Lead sponsor
Shandong First Medical University
Phase
Observational
Overall status
Unknown status
Start date
January 6, 2021
Completion date
December 31, 2024
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy effect, colorectal cancer, surgery